Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda

Questions? Call 800-624-6242

About | Ordering | New

LoginRegister

| Items in cart [0]

PAPERBACK
price:$33.00
add to cart

Rights & Permissions

Free PDF Access

Free Resources

Related Titles

Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993)
Institute of Medicine (IOM)

Citation Manager Export the bibliographic data for this book in your chosen format
Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web.
Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book.
Reference Finder Paste in your own text to find books that relate to your topic.

Citation Manager

. "B6. Uses of Antiprogestins After 63 Days of Amenorrhea." Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press, 1993.

Please select a format:

Page
182


E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.

Clinical Applications of Mifepristone (RU 486) and other Antiprogestins: Assessing the Science and Recommending a Research Agenda

between prostaglandin administration and expulsion in second trimester abortion. British Journal of Obstetrics and Gynaecology 97:41–45, 1990.

Stiemer, B., and Elger, W. Cervical ripening of the rat in dependence of endocrine milieu: Effects of antigestagens. Journal of Perinatal Medicine (Berlin) 18:419–429, 1990.

Thong, K.J., and Baird, D.T. A study of gemeprost alone, Dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy. Contraception 46:11–17, 1992.

Ulmann, A., Teutsch, G., and Philibert, D. RU 486. Scientific American 262:42–48, 1990.

Urquhart, D.R., Bahzad, C., and Templeton, A.A. Efficacy of the antiprogestin mifepristone (RU 486) prior to prostaglandin termination in pregnancy. Human Reproduction 4:202–203, 1989.

Wolf, J.P., Sinosich, M., Anderson, T.L., et al. Progesterone antagonist (RU 486) for cervical dilation, labor induction and delivery in monkeys: Effectiveness in combination with oxytocin. American Journal of Obstetrics and Gynecology 160:45–47, 1989.

World Health Organization (WHO). The use of mifepristone (RU 486) for cervical preparation in first trimester pregnancy termination by vacuum aspiration. British Journal of Obstetrics and Gynaecology 97:260–266, 1990.